Gross-to-Net 2022: An Industry Snapshot


Join Jen Sharpe, Vice President, Gross-to-Net Consulting, and facilitator of the Revenue Analytics Collaborative as she discusses the results of our recent GTN Benchmark survey. We’ll measure these results against previous years and share industry expertise and best practices to assess your GTN processes and methodologies. 

Topics covered include:

  • Medicaid, coverage gap, and price protection
  • Rebate and chargeback adjudication
  • Government pricing, budget, and regulation impacts
  • Inventory analytics, returns, and reserve forecasting


Interested in learning more about how IntegriChain helps pharma manufacturers optimize gross-to-net? Using data-driven models, we help companies achieve a confident forecast and clear view of a drug’s true net price.



Jennifer Sharpe
Vice President,
Gross-to-Net Consulting



adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article